CWC22

Pre-mRNA-splicing factor CWC22 homolog · Q9HCG8 · CWC22 on Sugi Atlas →

0 patent compounds predicted against CWC22, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CWC22 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100 PHASE1/PHASE2COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks nanRECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Uncovering the Etiologies of Non-immune Hydrops Fetalis nanENROLLING_BY_INVITATION
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients nanRECRUITING
Study of Constitutional Platelet Disease nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Genome Sequencing in the Intensive Care Unit Population nanENROLLING_BY_INVITATION
Genomic Predictors of Recurrent Pregnancy Loss nanRECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
PCD New Gene Discovery nanCOMPLETED
NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants nanCOMPLETED
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases nanRECRUITING
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Anthropogenetic Variability in the Group of Individuals With Febrile Seizures nanCOMPLETED
Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan nanENROLLING_BY_INVITATION
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions nanCOMPLETED
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN
Natural History Study of Patients With Neurofibromatosis Type 2 nanRECRUITING
A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CWC22 binder may also engage these)

ProteinNameSimilarity
Q5RA93 1.000 Q5RA93 →
Q8C5N3 1.000 Q8C5N3 →
A0A1I8M2I8 1.000 A0A1I8M2I8 →
Q5ZKA3 1.000 Q5ZKA3 →
Q08C72 1.000 Q08C72 →
Q52KN9 1.000 Q52KN9 →
Q9VJ87 0.993 Q9VJ87 →
U2SURP U2 snRNP-associated SURP motif-containing protein 0.993 landscape →
Q9P6R9 0.991 Q9P6R9 →
Q6NV83 0.991 Q6NV83 →
P0CM97 0.990 P0CM97 →
Q17336 0.990 Q17336 →
Q4PCY0 0.989 Q4PCY0 →
A8WT19 0.989 A8WT19 →
Q5R7X2 0.989 Q5R7X2 →
Q5RDD2 0.989 Q5RDD2 →
B3MJ69 0.987 B3MJ69 →
Q8HXH6 0.987 Q8HXH6 →
Q0P5I6 0.987 Q0P5I6 →
B4II37 0.987 B4II37 →
P0CM96 0.987 P0CM96 →
Q6DHU4 0.986 Q6DHU4 →
Q4FK66 0.986 Q4FK66 →
P24583 0.986 P24583 →
Q5TUF1 0.986 Q5TUF1 →
Q07205 0.986 Q07205 →
Q20448 0.986 Q20448 →
Q17FR9 0.986 Q17FR9 →
Q6BM04 0.985 Q6BM04 →
B6ZLK2 0.985 B6ZLK2 →